Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human primary fibroblasts (derived from ALS patients) | Human | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Milani et al., J. of Neuroinflammation, 2021, 18: 132, doi.org/10.1186/s12974-021-02184-1 | Link | |||
Mouse immortalized differentiated podocytes | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | J. G. Greiten et al., The FASEB Journal, 2021, 35: e21560, DOI: 10.1096/fj.202001179RR | Link | |||
Mouse fibroblast cell line, deficient of N-WASP | Mouse | unknown | cell line | adherent | plasmid | Metafectene | publication | S. Benesch et al., J. Cell Sci., Jul 2005; 118: 3103 - 3115 | Link | ||||
Human immortalized lymphocyte cell line (immortalized by EBV) | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | M. Pradas-Juni et al., Mol. Endocrinoly, 2014, 28(9): 1558-1570, doi: 10.1210/me.2014-1065 | Link | |||
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. L. Vasco et al., J. Cell Commun. Signal, 2014, 8:219-229, DOI 10.1007/s12079-014-0235-9 | Link | |
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. D’Angelo, Dissertation, University of Parma | Link | |
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., Anticancer Res, Aug 2014; 34: 4069 - 4075 | ||
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Leopizzi., PhD Thesis, 2018, University of Rome | Link | |
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., J. Cell Commun. Signal., 2015, 9:55-62; DOI 10.1007/s12079-015-0265-y | ||
143B |
Human osteosarcoma cell line | ATCC CRL-8304 | Human | bone | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
184A1 |
Human immortalized mammary epithelial cells | ATCC CRL-8798 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 | |||
1BR-hTERT |
Human hTERT-immortalized skin fibroblasts | Human | skin | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., Apr 2010; 19: 1324 - 1334 | Link | |||
1BR-hTERT |
Human hTERT-immortalized skin fibroblasts | Human | skin | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | H. Brunton et al., Mol. Cell. Biol., Oct 2011; 31: 4022 - 4035 | Link | |||
1BR.3 |
Human primary fibroblasts | Human | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz ez al., HMG Advance Access, 2016 | |||
1BR3hTERT |
Human hTERT immortalized fibroblasts | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | publication | K. M. Zimmerman, PhD Thesis, 2013, University of Sussex | Link | |||
1BRneo |
Human transformed fibroblasts | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
208pgsl |
Chinese hamster ovary cell line defective in UDP-xylose Synthase (derivat of CHO) | Hamster | genital tract | cell line | adherent | plasmid | Metafectene | publication | H. Bakker et al., J. Biol. Chem., Jan 2009; 284: 2576 - 2583 | Link | |||
208pgsl |
Chinese hamster ovary cell line defective in UDP-xylose Synthase (derivat of CHO) | Hamster | genital tract | cell line | adherent | plasmid | Metafectene | publication | A. Ashikov et al., Glycobiology, Mar 2013; 23: 303 - 309 | Link | |||
22Rv1 |
Human prostate epithelial cancer cell line | ATCC CRL-2505 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | M. Ansems et al., The Prostate, 2012, 72: 1708-1717, DOI 10.1002/pros.22522 | |||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | R. Feederle et al., J. Virol., May 2009; 83: 4952 - 4962 | Link | ||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | plasmid | Metafectene | publication | S. Barth et al., Nucleic Acids Res., Feb 2008; 36: 666 - 675 | Link | ||||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | R. Gonnella et al., Bioch. et Biophys. Acta, 2015, 1853: 1586-1595; doi.org/10.1016/j.bbamcr.2015.03.011 | Link | ||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | R. Feederle et al., J. Virol., Nov 2009; 83: 10877 - 10891 | Link | ||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | H. Nowag et al., EBioMedicine, 2014, 1 :116-125, doi.org/10.1016/j.ebiom.2014.11.007 | Link |